Here’s a collection of the news coverage of the Pharma & Biopharma Outsourcing Association’s activities. You can find more about our members at our News page, and you can also check out our blog for PBOA commentary.
- Global Business Reports – Interview with Gil Roth, President, PBOA (February 2022)
- Pink Sheet – Consortium Costs Debated As BARDA, Industry Discuss Plans For Next Pandemic Response – Bowman Cox (January 2022)
- DCAT Value Chain Insights – 5 MINUTES WITH: Gil Roth, President, Pharma & Biopharma Outsourcing Association (PBOA) (January 2022)
- Global Business Reports – Interview: Gil Roth, President, PBOA (February 2021)
- Wall Street Journal – Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them – by Elizabeth Koh (January 2021)
- Pharma’s Almanac – Nationalism and the Pharmaceutical Supply Chain – by Haig Armaghanian (December 2020)
- C&E News – C&EN’s Year in Pharma 2020: The pandemic thrust the drug industry into the global spotlight – by Lisa M. Jarvis (December 2020)
- Modern BioPharma Podcast – Interview: Gil Roth – Pharma and Biopharma Outsourcing Association – by Jesse McLaughlin (or video, if you dare) (September 2020)
- Pharmaceutical Technology – US government to grant up to $812M to newcomer Phlow Corporation for Covid-19 manufacturing: Bringing pharma home or ‘profiteering off pandemic’? (July 2020)
- Molecule To Market podcast – Advocating for the CDMO sector: Gil Roth, PBOA – by Raman Sehgal (July 2020)
- Pink Sheet – Hope Is Not A Plan: Manufacturing COVID-19 Therapeutics – by Bowman Cox (June 2020)
- Press Release: PBOA Members Committed To Continuing To Reliably Manufacture Drug and Vaccine Products (March 2020)
- RAPS – FDA Floats Idea of a Rating System for Drug Manufacturers – by Zachary Brennan (October 2019)
- Contract Pharma – Quality Metrics Feedback – by Gil Roth, PBOA (Sept. 2019)
- STAT News – Microbiome therapies could be the next frontier in medicine. But how exactly do you make them? – by Kate Sheridan (May 2019)
- The Medicine Maker – The Power List 2019
- Contract Pharma – CDMOs and Drug Shortages – by Gil Roth, PBOA (Sept. 2018)
- The Medicine Maker – Standing up for the Invisible Manufacturers – as told by Gil Roth (August 2018)
- RAPS Regulatory Focus – Could a Nonprofit Help With FDA’s Drug Shortage List? It’s Complicated – by Zachary Brennan
- R&D Magazine – INTERPHEX 2018 Introduced New Emphasis On CMOs And CDMOs – by Annie Keller (May 11, 2018)
- Contract Pharma – From OMUFA To Opioids – by Gil Roth (March 9, 2018)
- In-Pharma Technologist – Shortages and soaring generic prices prompt US hospitals to form not-for-profit drug business – by Flora Southey (January 25, 2018)
- C&E News – Perspectives: A new world for pharma contractors – by Gil Roth (October 9, 2017)
- Contract Pharma – FDARA and Beyond – by Gil Roth (September 6, 2017)
- In-Pharma Technologist – US FDA plans facility inspection efficiency drive – by Flora Southey (August 23, 2017)
- The Medicine Maker – Power List: Industry Influencers #6 (June 2017)
- Contract Pharma – Whither Washington? – by Gil Roth (March 7, 2017)
- Pharmaceutical Technology – Viewpoint: Challenges and Opportunities for CDMOs – by Gil Roth (February 2, 2017)
- Contract Pharma – GDUFA II Update – by Gil Roth (October 13, 2016)
- in-PharmaTechnologist.com – GDUFA II negotiations: CMOs to pay one third of facility fees – by Dan Stanton (September 28, 2016)
- The Pink Sheet – GDUFA II: ANDAs, Not Facilities Will Govern Revenue – by Derrick Gingery (September 26, 2016)
- BioProcess International – Making the Correct Outsourcing Decisions: BPI Theater Panelists at BIO 2016 Discuss Current and Future Needs for Contract Services – panel feat. Gil Roth, PBOA; Cory Lewis, Cook Pharmica; Andrew Sanford, Catalent Biologics; David Powell, Pfizer CentreOne; and Rajan Puri, Therapure Biomanufacturing (September 15, 2016)
- PBOA Statement on Reauthorization of the Generic Drug User Fee Amendments (August 31, 2016)
- BioProcess International – May Supplement Introduction: The Evolving Outsourcing Culture – by Gil Roth, PBOA (May 17, 2016)
- Biopharm International – Biopharma Outsourcing Market Expands – by Susan Haigney (March 1, 2016)
- Outsourcing-Pharma.com – Niche tech and biologics the new drivers for CMO consolidation, says PBOA (November 5, 2015) (with video, unfortunately)
- CPhI Pharma Insights – CMO/CDMO Challenges and Opportunities (PDF, beginning on page 46) (October 15, 2015)
- Pharmaceutical Outsourcing – CMOs and GDUFA: Shaping a New World (August 26, 2015)
- BioProcess International – The Contractor Perspective: A BPI Theater Roundtable at the 2015 BIO Convention (August 24, 2015)
- PharmTech – Interview: A Voice of Their Own (August 1, 2015)
- Bio/Pharmaceutical Outsourcing Report – PBOA Argues CMO Case on GDUFA Fees (June 29, 2015)
- Global Business Reports interview (June 18, 2015)
- Law 360 – Generic-Drug Makers Urge Changes To User-Fee Law (June 15, 2015)
- INTERPHEX Live – Video Interview: Organizing CMOs and CDMOs for a New World (May 15, 2015)
- PBOA Hosts Regulatory/Legislative Workshop (April 14, 2015)
- Outsourced Pharma – Pharma’s New Partner At Regulatory and Legislative Tables (April 13, 2015)
- Pharmaceutical Processing – Catalent Pharma Solutions Joins PBOA (April 8, 2015)
- Drug Development & Delivery – TraceLink Joins PBOA: New Affiliate Member Brings Serialization Expertise (April 6, 2015)
- TraceLink Discusses Global Serialization at PBOA Workshop (March 30, 2015)
- Outsourcing-Pharma.com – CMO group wants US FDA fees to be exempt from enforced budget cuts (March 3, 2015)
- Pharmaceutical Processing – Baxter BioPharma Solutions Joins PBOA; Nelson Patterson Elected To Board (January 21, 2015)
- Contract Pharma – Newsmakers: CMOs and CDMOs Have a Trade Association to Call Their Own (November 13, 2014)
- PBOA Elects Chairman (October 29, 2014)
- Contract Pharma – Pharma & Biopharma Outsourcing Association Formed (September 24, 2014)
- FDA transcript – PBOA testimony at GDUFA public hearing (Sept. 17, 2014)
